ImmunoPrecise Begins Path to NASDAQ

This morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to dual list their stock on the NASDAQ. In the news release, the company states they believe the move will gain greater exposure for the company to access a larger base of retail and institutional investors in the United States and internationally.

ImmunoPrecise Antibodies Ltd. Logo (CNW Group/ImmunoPrecise Antibodies Ltd.)

ImmunoPrecise is a full-service, therapeutic antibody discovery company utilizing species agnostic, multi-format, characterized and engineered, human monoclonal antibodies, on an abbreviated timeframe. IPA has developed a technology platform with end-to-end solutions empowering companies to discover and develop therapies against any disease. Their full-service capabilities reduce the time and risk associated with conventional multi-vendor product development.

The company has been working on COVID by identifying antibodies derived from multiple species (human, llama, Ligand’s humanized OmniRat, and wild-type rabbits) which demonstrate potent, in vitro neutralizing activity. They have discovered their functional antibodies using the Company’s DeepDisplay phage technology, B Cell Select and Single Step Hybridoma platforms.

At the time of publishing IPA stock is trading at $1.85 an increase of 3.9%.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Information for this analysis was found via Sedar and ImmunoPrecise Antibodies Ltd. The author is long common shares of ImmunoPrecise Antibodies (IPA.v). Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Empower Clinics Receives Repeat Order For 5,000 Test Kits

Empower Clinics (CSE: CBDT) this morning announced that it has received a notable purchase order...

Wednesday, April 14, 2021, 07:45:28 AM

US Energy Department: COVID-19 Pandemic Likely Caused By Lab Leak In China

According to American authorities, new intelligence has led the Energy Department to determine that an...

Monday, February 27, 2023, 10:58:59 AM

Canada Raises Foreign Aid Contributions by $485 Million Towards Global Covid-19 Effort

The Canadian federal government has announced plans to increase foreign spending by pledging an additional...

Tuesday, December 15, 2020, 02:13:41 PM

Bank Of Canada Pandemic Purchases Total To $795 Billion–Report

The COVID-19 pandemic triggered a global economic crisis, sending shockwaves through financial markets. In a...

Friday, October 13, 2023, 10:29:00 AM

Hong Kong To Enforce Stricter Measures To Keep COVID-19 Patients At Home

COVID-19 patients quarantined at home in Hong Kong will soon be required to wear a...

Monday, July 11, 2022, 04:35:00 PM